Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.230 | 1.500 | 0.270 |
Shares | 98.760 | 98.760 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.688 | 19.734 |
Price to Book | 2.778 | 3.904 |
Price to Sales | 4.928 | 5.520 |
Price to Cash Flow | 14.178 | 15.057 |
Dividend Yield | 0.524 | 0.495 |
5 Years Earnings Growth | 53.919 | 31.412 |
Number of long holdings: 49
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 10.09 | 408.18 | +0.72% | |
Alnylam | US02043Q1076 | 7.33 | 243.25 | +0.41% | |
Neurocrine | US64125C1099 | 5.12 | 136.53 | -0.34% | |
Moderna | US60770K1079 | 4.90 | 40.27 | +1.72% | |
Amgen | US0311621009 | 4.85 | 264.49 | +0.19% | |
Regeneron Pharma | US75886F1075 | 4.76 | 714.47 | -0.09% | |
AbbVie | US00287Y1091 | 4.25 | 180.00 | +0.90% | |
Denali Therapeutics | US24823R1059 | 3.85 | 20.92 | +0.67% | |
Biohaven Pharma | VGG1110E1079 | 3.50 | 35.75 | -1.11% | |
Guardant Health | US40131M1099 | 3.34 | 31.57 | +1.71% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.65B | 0.61 | 0.70 | - | ||
LU1300848345 | 6.65B | 0.85 | 1.00 | - | ||
LU1520716801 | 4.09B | 5.79 | 2.11 | - | ||
LU1323611266 | 4.09B | 3.95 | -0.16 | - | ||
UBS Lux Equity Fund China Opportuni | 2.89B | 9.57 | -10.68 | 4.90 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review